Company research
Synergy CHC Corp.
CIK 1562733Updated Sep 26, 2026
SecuritiesSNYR · NASDAQ · equitySNYRQ · OTC · equity
Historical securities (1)
SNYRD · OTC · equity · closed Oct 4, 2024Name history
Synergy Strips Corp. · through Aug 6, 2015Oro Capital Corporation, Inc. · through Apr 24, 2014
SNYR price & chart
Loading TradingView…
NASDAQ:SNYR on TradingView ↗About the company
We are a provider of consumer health care, beauty, and lifestyle products. Our current brand portfolio consists of two marquee brands, FOCUSfactor, a clinically-tested brain health supplement (this study was performed independently and is not related to any U.S. Food and Drug Administration (“FDA”) -approved investigational new drug (IND) application) that has been shown to improve memory, concentration and focus, and Flat Tummy, a lifestyle and wellness brand that provides a suite of nutritional products to help women achieve their nutrition and weight management goals. Collectively, these brands are referred to as nutraceuticals. Our products are sold through some of the nation’s leading club, mass drug, and other retailers such as Costco, Amazon.com, Walmart, Walgreens, BJ’s, and The Vitamin Shoppe. Additionally, we have expanded into Canada and Mexico.
In the news
Synergy CHC Corp. Announces Date Change of Fourth Quarter and Full Year 2025 Earnings and Conference Call ↗
Recent filings
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Items 3.01
Bankruptcy or Receivership · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 1.03, 5.02
Triggering Events That Accelerate or Increase a Direct Financial Obligation
Items 2.04
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · Regulation FD Disclosure
Items 3.01, 7.01, 9.01
Triggering Events That Accelerate or Increase a Direct Financial Obligation
Items 2.04
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2019 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 10,164,376Source | 16,343,101Source | 12,239,516Source | 5,190,629Source |
| Property, Plant and Equipment, NetUSD | — | — | — | 135,898Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 150,000Source | 283,333Source | 416,667Source | 7,636Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 2,622,313Source | 687,920Source | 632,534Source | 1,224,514Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 3,203,505Source | 5,321,037Source | 2,106,094Source | 1,423,786Source |
| Inventory, NetUSD | 3,737,509Source | 1,716,552Source | 3,726,240Source | 1,861,038Source |
| Assets, CurrentUSD | 10,014,376Source | 16,059,768Source | 11,822,849Source | 5,047,095Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 33,292,514Source | 32,974,444Source | 39,545,489Source | 10,393,980Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 114Source | 87Source | 76Source | 899Source |
| Additional Paid in CapitalUSD | — | 8,400,000Source | — | — |
| Retained Earnings (Accumulated Deficit)USD | -56,441,021Source | -44,099,813Source | -46,224,789Source | -24,234,569Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -154,281Source | -47,777Source | -102,467Source | 11,364Source |
| Stockholders' Equity Attributable to ParentUSD | -23,128,138Source | -16,631,343Source | -27,305,973Source | -5,203,351Source |
| Additional Paid in Capital, Common StockUSD | 33,594,550Source | 27,643,660Source | 19,148,707Source | 19,018,955Source |
| Liabilities and EquityUSD | 10,164,376Source | 16,343,101Source | 12,239,516Source | 5,190,629Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 8,236,068Source | 17,184,369Source | 14,021,882Source | 10,147,064Source |
| Additional Financial Items | ||||
| Accounts Receivable, after Allowance for Credit LossUSD | 3,203,505Source | 7,320,674Source | 2,106,094Source | — |
| Deferred Revenue, CurrentUSD | — | — | — | 7,887Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 25,056,446Source | 7,457,022Source | 13,096,610Source | — |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2019 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 133,334Source | 133,334Source | 33,333Source | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 136,247Source | — | — | 201,155Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -1,514,935Source | 3,214,943Source | -1,378,620Source | -3,027,900Source |
| Increase (Decrease) in InventoriesUSD | 2,915,298Source | -1,884,324Source | -3,990,456Source | -552,158Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -2,585,022Source | -4,803,390Source | 421,729Source | 2,946,350Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 4,654,664Source | 4,804,086Source | -2,090,782Source | -2,050,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 1,934,393Source | 55,386Source | -1,793,909Source | 728,598Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 2,722,313Source | 787,920Source | 732,534Source | — |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 2,953,878Source | 3,906,001Source | 4,174,895Source | 939,711Source |
| Income Taxes Paid, NetUSD | — | — | — | 38,919Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | 54,690Source | -124,856Source | — |
| Additional Financial Items | ||||
| AmortizationUSD | — | — | — | 1,077,987Source |
| Share-based Payment Arrangement, ExpenseUSD | 136,248Source | 0Source | 0Source | 161,570Source |
| Amortization of Debt Issuance CostsUSD | — | — | — | 130,829Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | 1,633,776Source | 56,796Source | 48,610Source | — |
| Amortization of Intangible AssetsUSD | 133,334Source | 133,334Source | 33,333Source | — |
| DepreciationUSD | — | — | — | 133,873Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -5,531Source | -54,321Source | 105,192Source | 1,308Source |
| Foreign Currency Transaction Gain (Loss), RealizedUSD | — | — | — | -8,280Source |
| Gain (Loss) on Sales of Loans, NetUSD | — | 30,000,000Source | 2,235,986Source | — |
| Gain (Loss) Related to Litigation SettlementUSD | — | — | 4,635,986Source | — |
| Gain (Loss) on Extinguishment of DebtUSD | 2,154,522Source | — | — | — |
| General and Administrative ExpenseUSD | 8,829,803Source | 4,717,006Source | 6,051,703Source | 5,493,433Source |
| Goodwill and Intangible Asset ImpairmentUSD | — | — | — | 9,715,137Source |
| Goodwill, Impairment LossUSD | — | — | — | 7,793,240Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | — | — | 471,897Source |
| Income Tax Expense (Benefit)USD | 117,471Source | 102,085Source | 234,980Source | -131,537Source |
| InterestExpenseNonoperatingUSD | 5,919,742Source | 4,105,198Source | 4,236,149Source | — |
| Inventory Write-downUSD | 894,341Source | 125,364Source | 251,021Source | 257,111Source |
| Investment Income, InterestUSD | 15,065Source | 1,523Source | 1,616Source | — |
| Net Income (Loss) Attributable to ParentUSD | -12,341,208Source | 2,124,976Source | 6,338,750Source | -9,207,447Source |
| Nonoperating Income (Expense)USD | -3,764,988Source | -3,574,187Source | -4,233,016Source | 1,119,800Source |
| Operating ExpensesUSD | 28,761,566Source | 17,841,771Source | 21,273,564Source | 28,176,054Source |
| Other Nonoperating Income (Expense)USD | 28,761,566Source | 17,841,771Source | 21,273,564Source | — |
| Payments of Financing CostsUSD | 2,024,287Source | — | — | — |
| Payments to Acquire InvestmentsUSD | 1,200,000Source | 1,200,000Source | — | — |
| Proceeds from Issuance of Common StockUSD | 3,719,547Source | 8,397,044Source | — | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2019 |
|---|---|---|---|---|
| Total RevenueUSD | — | — | — | 29,357,546Source |
| Cost of RevenueUSD | — | 11,191,224Source | 10,697,323Source | 9,137,602Source |
| Operating Income (Loss)USD | -8,458,749Source | 5,801,248Source | 10,806,746Source | -7,956,110Source |
| Other Nonoperating Income (Expense)USD | 28,761,566Source | 17,841,771Source | 21,273,564Source | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -12,223,737Source | 2,227,061Source | 6,573,730Source | -9,075,910Source |
| Income Tax Expense (Benefit)USD | 117,471Source | 102,085Source | 234,980Source | -131,537Source |
| Net Income (Loss) Attributable to ParentUSD | -12,341,208Source | 2,124,976Source | 6,338,750Source | -9,207,447Source |
| Earnings Per Share, BasicUSD per share | -1.27Source | 0.28Source | 0.86Source | -0.1Source |
| Earnings Per Share, DilutedUSD per share | -1.27Source | 0.28Source | 0.86Source | -0.1Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 9,722,552Source | 7,588,095Source | 7,373,745Source | 89,883,194Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 9,722,552Source | 7,630,501Source | 7,373,745Source | — |
| Interest Expense (non-operating)USD | 5,919,742Source | 4,105,198Source | 4,236,149Source | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 133,334Source | 133,334Source | 33,333Source | — |
| Current Income Tax Expense (Benefit)USD | 117,471Source | — | — | — |
| Depreciation, Depletion and Amortization, NonproductionUSD | 133,334Source | 133,334Source | 33,333Source | 1,211,861Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -5,531Source | -54,321Source | 105,192Source | 1,308Source |
| Foreign Currency Transaction Gain (Loss), RealizedUSD | — | — | — | -8,280Source |
| Gain (Loss) Related to Litigation SettlementUSD | — | — | 4,635,986Source | — |
| General and Administrative ExpenseUSD | 8,829,803Source | 4,717,006Source | 6,051,703Source | 5,493,433Source |
| Goodwill, Impairment LossUSD | — | — | — | 7,793,240Source |
| Gross ProfitUSD | 20,302,817Source | 23,643,019Source | 32,080,310Source | 20,219,944Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -9,765,518Source | — | — | — |
| Interest ExpenseUSD | — | 1,545,674Source | 1,693,642Source | — |
| Interest Expense, DebtUSD | 1,958,384Source | — | 1,545,674Source | — |
| Interest Income, OtherUSD | — | — | — | 414Source |
| Investment Income, InterestUSD | 15,065Source | 1,523Source | 1,616Source | — |
| Nonoperating Income (Expense)USD | -3,764,988Source | -3,574,187Source | -4,233,016Source | 1,119,800Source |
| Operating ExpensesUSD | 28,761,566Source | 17,841,771Source | 21,273,564Source | 28,176,054Source |
| Other IncomeUSD | — | 510,534Source | — | — |
| Selling and Marketing ExpenseUSD | 13,137,779Source | 12,991,431Source | 15,188,528Source | 11,471,652Source |
Offerings
Registration 333-295964
Registration 333-289645
- Gross proceeds
- 4375000.0
- Net proceeds
- 4068750.0
- Deal price
- 2.5
- Shares
- 1750000
- Offering price
- $2.50
- Ticker
- SNYR
Filing attachments
ea030294401ex99-1.htm · 8-K · 2026-08-21
EX-99.1 2 ea030294401ex99-1.htm PRESS RELEASE DATED AUGUST 21, 2026 Exhibit 99.1 Synergy CHC Corp. Announces Receipt of Nasdaq Letter N. WINDHAM, Maine, August 21, 2026 (GLOBE NEWSWIRE) - Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a consumer health and wellness company, today announced that it received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) on August 20, 2026, indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(…
Read attachment ↗ea029076501ex99-1.htm · 8-K · 2026-05-14
EX-99.1 2 ea029076501ex99-1.htm PRESS RELEASE, DATED MAY 14, 2026 Exhibit 99.1 Synergy CHC Corp. Reports First Quarter 2026 Financial Results N. WINDHAM, Maine, May 14, 2026 - Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a consumer health and wellness company, is announcing its financial results for the three months ended March 31, 2026. “Our first quarter results reflect continued execution and the growing momentum of our functional beverage business,” said Jack Ross, …
Read attachment ↗ea028992901ex4-1.htm · 8-K · 2026-05-11
EX-4.1 2 ea028992901ex4-1.htm COMMON STOCK PURCHASE WARRANT DATED MAY 8, 2026 Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEME…
Read attachment ↗ea028322301ex4-1.htm · 8-K · 2026-03-25
EX-4.1 2 ea028322301ex4-1.htm COMMON STOCK PURCHASE WARRANT, DATED AS OF MARCH 24, 2026, BY SYNERGY CHC CORP. TO ACME CREDIT PARTNERS FUND I, LP Exhibit 4.1 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, APPLICABLE STATE SECURITIES LAWS, OR APPLICABLE LAWS OF ANY FOREIGN JURISDICTION. THIS WARRANT AND SUCH UNDERLYING SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO DISTRIBUTION OR RESALE…
Read attachment ↗ea026529201ex99-1_synergy.htm · 8-K · 2025-11-13
EX-99.1 2 ea026529201ex99-1_synergy.htm PRESS RELEASE, DATED NOVEMBER 13, 2025 Exhibit 99.1 Synergy CHC Corp. Reports Third Quarter 2025 Financial Results and its Eleventh Consecutive Quarter of Profitability WESTBROOK, Maine, November 13, 2025 - Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, is announcing its financial results for the three months ended September 30, 2025. “We are pleased to report our 11th quarter of profi…
Read attachment ↗ea025810601ex99-1_synergy.htm · 8-K · 2025-09-22
EX-99.1 2 ea025810601ex99-1_synergy.htm PRESS RELEASE DATED SEPTEMBER 22, 2025 Exhibit 99.1 Synergy CHC (NASDAQ: SNYR) Taps Former Coca-Cola Executive to Lead Strategic Partnerships; Appoints Veteran Costco Buyer to Board of Directors Board member Scott Woodburn transitions to Head of Strategic Partnerships to accelerate FOCUSfactor Energy Drink expansion Former Costco Buyer Teresa Thompson brings nearly 40 years of retail expertise in vitamins and supplements WESTBROOK, Maine, September…
Read attachment ↗